Orogurd 2% w/w (Oral Gel)

15 gm tube: ৳ 60.00

Medicine Details

Categories

  • Derivatives
  • Antifungal Medication
  • Oral Gel
  • Topical Cream

Age Group

  • Infants (4-24 months)
  • Children (2 years and older)
  • Adults

Dosage Form

  • Oral Gel
  • Cream

Indications

  • Treatment of oral and gastrointestinal candidiasis
  • Eradication of fungal colonization
  • Treatment of super infections due to gram-positive bacteria
  • Dermatomycoses such as tinea pedis, tinea corporis, tinea manuum, tinea cruris, candidial infections, tinea versicolor, skin infections, perianal infections, stomatitis angularis, balanoposthitis, otitis externa

Pharmacodynamics

  • Antifungal activity against dermatophytes and yeasts
  • Antibacterial activity against certain gram-positive bacilli and cocci
  • Inhibition of demethylation step in ergosterol biosynthesis
  • Disruption of fungal cell membrane leading to cell death

Pharmacokinetics

  • Low oral bioavailability (25-30%)
  • Systemic absorption after oral gel administration
  • Binding to plasma proteins (88.2%)
  • Metabolism of absorbed portion
  • Excretion in urine (less than 1%)
  • Terminal plasma half-life (20-25 hours)

Administration

  • Application 2-4 times a day directly to affected area
  • Removal of dental prosthesis at night and brushing with the gel
  • Continued treatment for at least a week after symptoms disappear

Interactions

  • Avoidance of concomitant treatment with Terfenadine, Astemizole, or Cisapride
  • Potential delay of Phenytoin and Cyclosporine metabolism

Contraindications

  • Known hypersensitivity to the active ingredient

Side Effects

  • Occasional nausea and vomiting
  • Diarrhea with long term use
  • Rare allergic reactions

Pregnancy & Lactation

  • No safety information during pregnancy
  • Caution in nursing women

Precautions & Warnings

  • Monitoring of anti-coagulant effect and phenytoin plasma levels
  • Caution in infants and young children to prevent throat obstruction

Overdose Effects

  • Symptomatic and supportive treatment
  • Vomiting and diarrhea

Therapeutic Class

  • Aural Anti-fungal preparations

Storage Conditions

  • Dry place away from light and heat
  • Keep out of the reach of children

Usability

  • Relief of symptoms in 2-3 days
  • Clinical improvement soon after treatment begins
  • Lesions usually disappear after 2-5 weeks

Preventive Treatment Duration

  • 10 days to prevent relapse
  • Two weeks for Candida infections, tinea cruris and corporis
  • One month for tinea pedis

Absorption in Gastrointestinal Tract Candidosis

  • Low absorption from intestinal tract
  • 20 mg per kg body weight per day
  • Daily dose not to exceed 250 mg (10 ml gel)

Missed Dose

  • Apply missed dose as soon as remembered
  • Omit missed dose if close to next dosing time

Application of Miconazole Cream

  • Twice daily for tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis
  • Once daily for tinea versicolor
  • Sparingly in intertriginous areas

Rapid Alleviating Effect

  • On pruritus which often accompanies infections

Reduction of Possibility of Recurrence

  • Two weeks for Candida infections, tinea cruris and corporis
  • One month for tinea pedis

Efficacy in Candidiasis

  • Very rapid alleviating effect on pruritis

Antidote for Overdose

  • Not available

Avoidance of Anticoagulant Interaction

  • Monitor and titrate anti-coagulant effect

Caution in Drug Excretion via Breast Milk

  • Exercise caution in nursing women

Effect on Fungal Cell Membrane

  • Disruption leading to cell death

Caution in Infants and Young Children

  • To ensure gel does not obstruct the throat

Immune Response

  • Rare allergic reactions

Drug Excretion

  • Less than 1% excreted unchanged in urine

Potential Toxicity

  • Potential toxicity of Phenytoin and Cyclosporine when metabolism is delayed

Application Frequency

  • 2-4 times a day for localized lesions of the mouth

Duration of Treatment for Recurrence Prevention

  • 10 days to prevent relapse
  • Two weeks for Candida infections, tinea cruris and corporis
  • One month for tinea pedis

Binding to Plasma Proteins

  • Primary binding to serum albumin and red blood cells

Metabolism of Absorbed Miconazole

  • Largely metabolized after systemic absorption

Elimination Half-life

  • Similar in any renal-impaired patient

Effect on Ergosterol Biosynthesis

  • Inhibition of a demethylation step

Disruption of Fungal Cell Membrane

  • Causing holes to appear and cell death

Storage Precaution

  • Keep away from light and heat

Child-Safe Storage

  • Keep out of the reach of children

Related Brands